Iron (III) citrate, substantially free of beta-iron hydroxide oxide

US9624155B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9624155-B2
Application numberUS-201414184062-A
CountryUS
Kind codeB2
Filing dateFeb 19, 2014
Priority dateJan 18, 2011
Publication dateApr 18, 2017
Grant dateApr 18, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention provides a method for producing high-purity iron(III) citrate substantially free of beta-iron hydroxide oxide, high-purity iron(III) citrate substantially free of beta-iron hydroxide oxide, and medical uses thereof.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for producing iron(III) citrate comprising: a step of forming an iron-containing precipitate comprising bringing ferric chloride into contact with sodium hydroxide in an aqueous medium for a duration of two hours or less at a liquid temperature of 0° C. to 10° C. to form an iron-containing precipitate; a step of generating an aqueous solution of iron(III) citrate comprising bringing citric acid into contact with the iron-containing precipitate in an aqueous medium and generating an aqueous solution of iron(III) citrate via heating; and a step of precipitating iron(III) citrate comprising bringing the aqueous solution of iron(III) citrate into contact with an organic solvent to precipitate the iron(III) citrate. 2. The method according to claim 1 , wherein the step of generating an aqueous solution of iron(III) citrate comprises bringing citric acid into contact with the iron-containing precipitate at a liquid temperature of 60° C. to 100° C. 3. The method according to claim 1 , wherein the iron-containing precipitate is ferrihydride. 4. The method according to claim 1 , wherein the duration during which ferric chloride is in contact with sodium hydroxide is one hour or less. 5. The method according to claim 1 , wherein the duration during which ferric chloride is in contact with sodium hydroxide is 30 minutes or less. 6. The method according to claim 1 , wherein the step of forming an iron-containing precipitate comprises bringing ferric chloride into contact with sodium hydroxide in an aqueous medium at a liquid temperature of lower than 10° C. 7. The method according to claim 1 , wherein the step of forming an iron-containing precipitate comprises bringing ferric chloride into contact with sodium hydroxide in an aqueous medium at a liquid temperature of 3.5° C. to 8° C. 8. The method according to claim 1 , wherein the step of forming an iron-containing precipitate comprises bringing ferric chloride into contact with sodium hydroxide in an aqueous medium at a liquid temperature of 2.6° C. to 7.5° C. 9. The method according to claim 1 , wherein the step of forming an iron-containing precipitate comprises bringing ferric chloride into contact with sodium hydroxide in an aqueous medium at a liquid temperature of 2.6° C. to 7.6° C. 10. The method according to claim 1 , wherein the step of forming an iron-containing precipitate comprises bringing ferric chloride into contact with sodium hydroxide in an aqueous medium at a liquid temperature of 0° C. to 7.3° C. 11. The method according to claim 1 , wherein the step of forming an iron-containing precipitate comprises bringing ferric chloride into contact with sodium hydroxide in an aqueous medium at a liquid temperature of 1.3° C. to 8.3° C. 12. The method according to claim 1 , wherein the step of forming an iron-containing precipitate comprises bringing ferric chloride into contact with sodium hydroxide in an aqueous medium at a liquid temperature of 2.5° C. to 8.4° C. 13. The method according to claim 1 , wherein the step of forming an iron-containing precipitate comprises bringing ferric chloride into contact with sodium hydroxide in an aqueous medium at a liquid temperature of 1.9° C. to 8.0° C. 14. The method according to claim 1 , wherein the step of forming an iron-containing precipitate comprises bringing ferric chloride into contact with sodium hydroxide in an aqueous medium at a liquid temperature of 1.4° C. to 8.3° C. 15. The method according to claim 1 , wherein the step of forming an iron-containing precipitate comprises bringing ferric chloride into contact with sodium hydroxide in an aqueous medium at a liquid temperature of 2.2° C. to 9.1° C. 16. The method according to claim 1 , wherein the step of forming an iron-containing precipitate comprises bringing ferric chloride into contact with sodium hydroxide in an aqueous medium at a liquid temperature of 3.0° C. to 5.3° C.

Assignees

Inventors

Classifications

  • Drugs for disorders of the blood or the extracellular fluid · CPC title

  • Antidotes · CPC title

  • Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00) · CPC title

  • for electrolyte homeostasis · CPC title

  • of the kidneys · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9624155B2 cover?
This invention provides a method for producing high-purity iron(III) citrate substantially free of beta-iron hydroxide oxide, high-purity iron(III) citrate substantially free of beta-iron hydroxide oxide, and medical uses thereof.
Who is the assignee on this patent?
Japan Tobacco Inc
What technology area does this patent fall under?
Primary CPC classification C07C51/412. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).